Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition

NCT04542291 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Pancreas Cancer
Pancreatic Cancer
Cancer of the Pancreas

Interventions

DRUG: Dapagliflozin
DEVICE: BIOSENSE meters

Sponsor

Washington University School of Medicine

Collaborators

[object Object]
[object Object]